| Last Price | 15.72 | Max Price | 15.72 |
| Min Price | 14.34 | 1 Year return | 0.00 |
| Avg. Target | 0.00 | Expected Return | - |
| Sector | Health Care | Subsector | Health Care Eq. & Services |
| Sell | 0 | Rating | |
| Hold | 0 | Concensus | |
| Buy | 0 |
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 0 | 1,914,856 | 0.00 % |
| 2020 | 0 | 1,909,941 | 0.00 % |
| 2021 | 0 | 2,244,427 | 0.00 % |
| 2022 | 0 | 2,638,646 | 0.00 % |
| 2023 | 0 | 2,748,111 | 0.00 % |
No Records Found
No Records Found
No Records Found
Over the past 10 years the global health care companies gained around 102 percent. Since 2011 the sector is 64 percent higher and over the past year plus 102 percent.
LifeWatch didn't pay out any dividends (in the past 5 years).
At the end of 2015 LifeWatch employed at around 1274 thousand people.
At the end of 2015 the health care company's balance sheet equaled 79,46 million CHFF. 53,65 million CHFF (67,52 percent of the total balance sheet) was financed by debt. At the end of 2016 the Swiss company was traded with a price/earnings-ratio of around -14. So investors paid -14 times the company's 2015's EPS. Based on it's price/earnings-ratio and dividend yield the Swiss stock can be seen as a value stock.
At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 239,39 million CHFF. At the end of 2015 the Swiss company had around 13,41 million stocks listed.
At this page you find all LifeWatch's financial reports. More information about LifeWatch can be found it's website. .
| Results |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Revenue |
|
|
|
|
|
| Costs |
|
|
|
|
|
| Profit |
|
|
|
|
|
| Margin of profit |
|
|
|
|
|
| ROI |
|
|
|
|
|
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
0.0
|
0.0
|
0.0
|
0.0
|
15.72
|
| Eps |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow per stock |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Stocks |
0
|
0
|
0
|
0
|
|
| Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
|
|
Date
|
Price
|
|---|---|
|
14 Apr 2026
|
15.72
|
|
28 Jan 2026
|
14.34
|